Immunological Characterization of Proteins Expressed by Genes Located in Mycobacterium tuberculosis-Specific Genomic Regions Encoding the ESAT6-like Proteins
Open Access
- 7 January 2021
- Vol. 9 (1), 27
- https://doi.org/10.3390/vaccines9010027
Abstract
The 6 kDa early secreted antigen target (ESAT6) is a low molecular weight and highly immunogenic protein of Mycobacterium tuberculosis with relevance in the diagnosis of tuberculosis and subunit vaccine development. The gene encoding the ESAT6 protein is located in the M. tuberculosis-specific genomic region known as the region of difference (RD)1. There are 11 M. tuberculosis-specific RDs absent in all of the vaccine strains of BCG, and three of them (RD1, RD7, and RD9) encode immunodominant proteins. Each of these RDs has genes for a pair of ESAT6-like proteins. The immunological characterizations of all the possible proteins encoded by genes in RD1, RD7 and RD9 have shown that, besides ESAT-6 like proteins, several other proteins are major antigens useful for the development of subunit vaccines to substitute or supplement BCG. Furthermore, some of these proteins may replace the purified protein derivative of M. tuberculosis in the specific diagnosis of tuberculosis by using interferon-gamma release assays and/or tuberculin-type skin tests. At least three subunit vaccine candidates containing ESAT6-like proteins as antigen components of multimeric proteins have shown efficacy in phase 1 and phase II clinical trials in humans.Keywords
This publication has 220 references indexed in Scilit:
- Tuberculosis vaccines: beyond bacille Calmette–GuérinPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2011
- Comparative Evaluation of MPT83 (Rv2873) for T Helper-1 Cell Reactivity and Identification of HLA-Promiscuous Peptides in Mycobacterium bovis BCG-Vaccinated Healthy SubjectsClinical and Vaccine Immunology, 2011
- Identification, Diagnostic Potential, and Natural Expression of Immunodominant Seroreactive Peptides Encoded by Five Mycobacterium tuberculosis -Specific Genomic RegionsClinical and Vaccine Immunology, 2011
- Screening of Predicted Secreted Antigens from Mycobacterium bovis Identifies Potential Novel Differential Diagnostic ReagentsClinical and Vaccine Immunology, 2010
- Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and non-diabetic tuberculosis patients andMycobacterium bovisbacilli Calmette–Guérin (BCG)-vaccinated healthy subjectsClinical and Experimental Immunology, 2009
- Discordant QuantiFERON-TB Gold Test Results Among US Healthcare Workers With Increased Risk of Latent Tuberculosis Infection: A Problem or Solution?Infection Control & Hospital Epidemiology, 2008
- Efficient Testing of Large Pools of Mycobacterium tuberculosis RD1 Peptides and Identification of Major Antigens and Immunodominant Peptides Recognized by Human Th1 CellsClinical and Vaccine Immunology, 2008
- Double-blind randomized Phase I study comparing rdESAT-6 to tuberculin as skin test reagent in the diagnosis of tuberculosis infectionTuberculosis, 2008
- Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosisNature Medicine, 2003
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998